Dysregulated Mineral Metabolism in AKI.

[1]  Javier A. Neyra,et al.  Fibroblast Growth Factor 23 and Klotho in AKI. , 2019, Seminars in nephrology.

[2]  C. Faul,et al.  FGF23 Actions on Target Tissues—With and Without Klotho , 2018, Front. Endocrinol..

[3]  D. Leaf,et al.  Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[4]  T. Yoo,et al.  Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy , 2018, PloS one.

[5]  M. Mohammadi,et al.  αKlotho is a Non-Enzymatic Molecular Scaffold for FGF23 Hormone Signaling , 2018, Nature.

[6]  C. Marcocci,et al.  Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis. , 2018, Frontiers of hormone research.

[7]  S. Erickson,et al.  Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients , 2018, Journal of Nephrology.

[8]  T. Nickolas,et al.  KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Javier A. Neyra,et al.  Potential application of klotho in human chronic kidney disease. , 2017, Bone.

[10]  L. Forni,et al.  Vitamin D levels in critically ill patients with acute kidney injury: a protocol for a prospective cohort study (VID-AKI) , 2017, BMJ Open.

[11]  D. Leaf,et al.  Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. , 2017, Journal of the American Society of Nephrology : JASN.

[12]  T. Pisitkun,et al.  Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus. , 2017, Kidney international.

[13]  K. White,et al.  Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels , 2017, Endocrinology.

[14]  Manish Kaushik,et al.  Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events , 2017, Clinical kidney journal.

[15]  J. Melnick,et al.  Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease , 2016, American Journal of Nephrology.

[16]  Dong Ki Kim,et al.  Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy , 2016, Medicine.

[17]  D. Leaf,et al.  Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. , 2016, Kidney International.

[18]  A. Ferrante,et al.  The Non-Genomic Actions of Vitamin D , 2016, Nutrients.

[19]  T. Dschietzig,et al.  Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography , 2016, PloS one.

[20]  J. Laurila,et al.  Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: Observational FINNAKI cohort study , 2016, Annals of medicine.

[21]  M. Wolf,et al.  Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production , 2015, Kidney international.

[22]  Samuel H. Gellman,et al.  PTH receptor-1 signalling—mechanistic insights and therapeutic prospects , 2015, Nature Reviews Endocrinology.

[23]  G. Perkins,et al.  Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) , 2015, Thorax.

[24]  D. Canale,et al.  Vitamin D deficiency aggravates ischemic acute kidney injury in rats , 2015, Physiological reports.

[25]  M. Mohammadi,et al.  The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  A. Vijayan,et al.  Relationship of 1,25 dihydroxy Vitamin D Levels to Clinical Outcomes in Critically Ill Patients with Acute Kidney Injury. , 2015, Journal of nephrology & therapeutics.

[27]  D. Elashoff,et al.  Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients , 2015, Pediatric Nephrology.

[28]  K. Amrein,et al.  Native and active vitamin D in intensive care: who and how we treat is crucially important. , 2014, American journal of respiratory and critical care medicine.

[29]  P. A. Friedman,et al.  Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[30]  A. Berghold,et al.  Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. , 2014, JAMA.

[31]  D. Leaf,et al.  Randomized controlled trial of calcitriol in severe sepsis. , 2014, American journal of respiratory and critical care medicine.

[32]  T. Pieber,et al.  Vitamin D status and its association with season, hospital and sepsis mortality in critical illness , 2014, Critical Care.

[33]  K. Wu,et al.  The Impact of Acute Kidney Injury With Temporary Dialysis on the Risk of Fracture , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Myung-Gyu Kim,et al.  Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury. , 2014, Biochemical and biophysical research communications.

[35]  S. Rivella,et al.  FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis* , 2014, The Journal of Biological Chemistry.

[36]  B. Lanske,et al.  FGF23 promotes renal calcium reabsorption through the TRPV5 channel , 2014, The EMBO journal.

[37]  K. Nath.  Heme oxygenase-1 and acute kidney injury , 2014, Current opinion in nephrology and hypertension.

[38]  T. Pieber,et al.  High-dose cholecalciferol supplementation significantly increases peripheral CD4+ Tregs in healthy adults without negatively affecting the frequency of other immune cells , 2014, European Journal of Nutrition.

[39]  H. Bischoff-Ferrari,et al.  Pharmacokinetics of oral vitamin D3 and calcifediol. , 2014, Bone.

[40]  Farsad Afshinnia,et al.  Effect of ionized serum calcium on outcomes in acute kidney injury needing renal replacement therapy: secondary analysis of the acute renal failure trial network study , 2013, Renal failure.

[41]  D. Leaf,et al.  Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes , 2013, Clinical endocrinology.

[42]  M. Şeneş,et al.  Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia/reperfusion injury in rats. , 2013, Annals of the Royal College of Surgeons of England.

[43]  J. Tisdale,et al.  QT interval prolongation and the risk of torsades de pointes: essentials for clinicians , 2013, Current medical research and opinion.

[44]  H. Armbrecht,et al.  FGF-23 Regulates CYP27B1 Transcription in the Kidney and in Extra-Renal Tissues , 2013, PloS one.

[45]  C. Mathieu,et al.  Vitamin D action: lessons from VDR and Cyp27b1 null mice. , 2013, Pediatric endocrinology reviews : PER.

[46]  S. Waikar,et al.  Phosphate balance in continuous venovenous hemofiltration. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  A. Goulart,et al.  Decreased parathyroid hormone levels despite persistent hypocalcemia in patients with kidney failure recovering from septic shock. , 2013, Endocrine, metabolic & immune disorders drug targets.

[48]  C. Hao,et al.  Is the Serum Vitamin D Level at the Time of Hospital-Acquired Acute Kidney Injury Diagnosis Associated with Prognosis? , 2013, PloS one.

[49]  D. Stein,et al.  Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: The role of BDNF/TrkB/Erk1/2 signaling in neuroprotection , 2013, Neuropharmacology.

[50]  J. Navarro-González,et al.  Anti‐Inflammatory Profile of Paricalcitol in Hemodialysis Patients: A Prospective, Open‐Label, Pilot Study , 2013, Journal of clinical pharmacology.

[51]  Ş. Güney,et al.  Protective Effect of Melatonin and 1,25-Dihydroxyvitamin D3 on Renal Ischemia–Reperfusion Injury in Rats , 2013, Renal failure.

[52]  O. Verbitsky,et al.  The role of vitamin D receptor in innate and adaptive immunity: a study in hereditary vitamin D-resistant rickets patients. , 2013, The Journal of clinical endocrinology and metabolism.

[53]  J. Bacchetta,et al.  Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25‐dihydroxyvitamin D in human monocytes , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  Yunxin J. Jiao,et al.  Secreted Factors from Bone Marrow Stromal Cells Upregulate IL-10 and Reverse Acute Kidney Injury , 2012, Stem cells international.

[55]  E. Farrow,et al.  Circulating αKlotho influences phosphate handling by controlling FGF23 production. , 2012, The Journal of clinical investigation.

[56]  E. Giovannucci,et al.  Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill* , 2012, Critical care medicine.

[57]  C. Mathieu,et al.  Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes , 2012, American Journal of Nephrology.

[58]  Herbert Chase,et al.  FGF-23 levels in patients with AKI and risk of adverse outcomes. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[59]  F. Theilig,et al.  Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney. , 2012, Kidney international.

[60]  E. Bae,et al.  Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. , 2012, European journal of pharmacology.

[61]  B. Kestenbaum,et al.  The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease , 2012, Kidney international.

[62]  Jun-Feng Wang,et al.  Heme oxygenase-1 system, inflammation and ventilator-induced lung injury. , 2012, European journal of pharmacology.

[63]  E. Farrow,et al.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice , 2011, Proceedings of the National Academy of Sciences.

[64]  Jiang He,et al.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. , 2011, JAMA.

[65]  Chi-yuan Hsu,et al.  FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study , 2011, Annals of intensive care.

[66]  Huiliang Xie,et al.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. , 2011, Kidney international.

[67]  C. Camargo,et al.  Vitamin D insufficiency and sepsis severity in emergency department patients with suspected infection. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[68]  E. Giovannucci,et al.  Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill* , 2011, Critical care medicine.

[69]  T. Pieber,et al.  Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study , 2011, Critical care.

[70]  H. Friberg,et al.  Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy , 2011, Acta anaesthesiologica Scandinavica.

[71]  M. Kuro-o,et al.  Klotho deficiency causes vascular calcification in chronic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[72]  Hwan-Suck Chung,et al.  CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. , 2010, Kidney international.

[73]  Hyoung-Kyu kim,et al.  The role of Tregs and CD11c(+) macrophages/dendritic cells in ischemic preconditioning of the kidney. , 2010, Kidney international.

[74]  T. Shimada,et al.  Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. , 2010, Kidney international.

[75]  Gavin Giovannoni,et al.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. , 2010, Genome research.

[76]  J. Silver,et al.  PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. , 2010, American journal of physiology. Renal physiology.

[77]  K. Rosenblatt,et al.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  Amit X Garg,et al.  The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods , 2010, BMC nephrology.

[79]  H. Leffers,et al.  Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  E. Bae,et al.  Paricalcitol attenuates cyclosporine-induced kidney injury in rats. , 2010, Kidney international.

[81]  V. Debari,et al.  Association of hypophosphatemia with failure-to-wean from mechanical ventilation. , 2010, Annals of clinical and laboratory science.

[82]  T. Pieber,et al.  Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? , 2010, The Israel Medical Association journal : IMAJ.

[83]  E. Bae,et al.  Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats. , 2010, American journal of physiology. Renal physiology.

[84]  H. Jüppner,et al.  Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. , 2010, Annual review of medicine.

[85]  Zhentao Zhang,et al.  1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1 , 2010, BMC Genomics.

[86]  Liping Huang,et al.  Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. , 2009, Journal of the American Society of Nephrology : JASN.

[87]  S. Cha,et al.  Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by Klotho , 2009, Molecular Pharmacology.

[88]  M. J. Santiago,et al.  Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. , 2009, Kidney international.

[89]  Judith K Jones,et al.  Risk of Further Decline in Renal Function After the Use of Oral Sodium Phosphate or Polyethylene Glycol in Patients With a Preexisting Glomerular Filtration Rate Below 60 ml/min , 2008, The American Journal of Gastroenterology.

[90]  H. Rennke,et al.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[91]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[92]  P. Houillier,et al.  Pitfalls of measuring total blood calcium in patients with CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[93]  P. Peduzzi,et al.  Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.

[94]  J. Adams,et al.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[95]  C. Ohlsson,et al.  Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[96]  M. Mohammadi,et al.  The parathyroid is a target organ for FGF23 in rats. , 2007, The Journal of clinical investigation.

[97]  Shinzo Tanaka,et al.  α-Klotho as a Regulator of Calcium Homeostasis , 2007, Science.

[98]  J. Alam,et al.  Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. , 2007, The American journal of pathology.

[99]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[100]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 regulates genes responsible for detoxification in intestine. , 2007, Toxicology and applied pharmacology.

[101]  K. Okawa,et al.  Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.

[102]  Youhua Liu,et al.  Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. , 2006, Journal of the American Society of Nephrology : JASN.

[103]  Hang Lee,et al.  Regulation of C‐Terminal and Intact FGF‐23 by Dietary Phosphate in Men and Women , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[104]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[105]  J. Potts.  Parathyroid hormone: past and present. , 2005, The Journal of endocrinology.

[106]  Giuseppe Penna,et al.  Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. , 2005, Blood.

[107]  Jai Radhakrishnan,et al.  Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[108]  J. Hoenderop,et al.  Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone. , 2005, Kidney international.

[109]  S. Kato,et al.  Role of the vitamin D receptor in FGF23 action on phosphate metabolism. , 2005, The Biochemical journal.

[110]  G. Hendy,et al.  Calcium-sensing Receptor Gene Transcription Is Up-regulated by the Proinflammatory Cytokine, Interleukin-1β , 2005, Journal of Biological Chemistry.

[111]  R. S. Smith,et al.  A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. , 2005, American journal of surgery.

[112]  C. Lange,et al.  Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. , 2005, American journal of physiology. Renal physiology.

[113]  S. Kato,et al.  Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo* , 2005, Journal of Biological Chemistry.

[114]  Karl Zilles,et al.  Effects of 1α,25 dihydroxyvitamin D3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex , 2004, Journal of Chemical Neuroanatomy.

[115]  D. Metzger,et al.  Long on QT and low on calcium , 2004, Cardiology in the Young.

[116]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[117]  Martha H Meyer,et al.  The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia. , 2004, Physiological genomics.

[118]  V. D’Agati,et al.  Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. , 2004, Human pathology.

[119]  Y. Gumurdulu,et al.  Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation , 2004, Journal of gastroenterology and hepatology.

[120]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[121]  P. V. D. van der Voort,et al.  Albumin-adjusted calcium is not suitable for diagnosis of hyper- and hypocalcemia in the critically ill , 2003, Critical care medicine.

[122]  K. White,et al.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. , 2003, The New England journal of medicine.

[123]  H. Kronenberg.  NPT2a--the key to phosphate homeostasis. , 2002, The New England journal of medicine.

[124]  Jonathan T. Wang,et al.  Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1α-Hydroxylase Gene Expression in the Proximal Renal Tubule. , 2002, Endocrinology.

[125]  L. Adorini,et al.  Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1 , 2001, The Journal of Immunology.

[126]  S. Ohashi,et al.  A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. , 2001, The American journal of pathology.

[127]  R. Bellomo,et al.  Phosphatemic Control during Acute Renal Failure: Intermittent Hemodialysis versus Continuous Hemodiafiltration , 2001, The International journal of artificial organs.

[128]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[129]  D. Churchill,et al.  Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[130]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[131]  E. Takeda,et al.  Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. , 1999, The Biochemical journal.

[132]  E. Slatopolsky,et al.  Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone. , 1999, Journal of the American Society of Nephrology : JASN.

[133]  Henrik Vorum,et al.  An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3 , 1999, Cell.

[134]  R. Apsner,et al.  Fat-Soluble Vitamins in Patients with Acute Renal Failure , 1998, Mineral and Electrolyte Metabolism.

[135]  R. Nagai,et al.  Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. , 1998, Biochemical and biophysical research communications.

[136]  U Ziegler,et al.  Parathyroid Hormone-dependent Degradation of Type II Na+/Pi Cotransporters* , 1997, The Journal of Biological Chemistry.

[137]  S. Hebert,et al.  Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. , 1996, The American journal of physiology.

[138]  K. Lu,et al.  A prospective study of calcium metabolism in exertional heat stroke with rhabdomyolysis and acute renal failure. , 1995, Nephron.

[139]  B. Hoffman,et al.  Predicting survival in fulminant hepatic failure using serum gc protein concentrations , 1995, Hepatology.

[140]  R. Hotchkiss,et al.  Increased intracellular Ca2+: a critical link in the pathophysiology of sepsis? , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[141]  R. Mayer,et al.  Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. , 1993, The Journal of pharmacology and experimental therapeutics.

[142]  J. Mustonen,et al.  Metabolism of calcium and vitamin D3 in patients with acute tubulointerstitial nephritis: a study of 41 patients with nephropathia epidemica. , 1993, Nephron.

[143]  H. DeLuca,et al.  Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[144]  B. Chernow,et al.  Hypocalcemia in critically ill patients , 1982, Critical care medicine.

[145]  J. Silver,et al.  Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. , 1990, The Journal of clinical investigation.

[146]  G. Capasso,et al.  Parathyroidectomy has a beneficial effect on experimental cisplatin nephrotoxicity. , 1990, Clinical nephrology.

[147]  O. Siggaard‐Andersen,et al.  Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. , 1989, Scandinavian journal of clinical and laboratory investigation.

[148]  T. Akiyama,et al.  Hypocalcemic Torsades de Pointes. , 1989, Journal of electrocardiology.

[149]  Y. Ohyama,et al.  Purification and characterization of vitamin D 25-hydroxylase from rat liver mitochondria. , 1988, The Journal of biological chemistry.

[150]  W. Dzik,et al.  Citrate toxicity during massive blood transfusion. , 1988, Transfusion medicine reviews.

[151]  K. O̸lgaard,et al.  Metabolism of intact parathyroid hormone in isolated perfused rat liver and kidney. , 1988, The American journal of physiology.

[152]  E. Slatopolsky,et al.  Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. , 1987, Kidney international.

[153]  W. C. Elliott,et al.  Effect of parathyroid hormone activity on gentamicin nephrotoxicity. , 1987, The Journal of laboratory and clinical medicine.

[154]  J. Silver,et al.  Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. , 1986, The Journal of clinical investigation.

[155]  P. McSheehy,et al.  Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. , 1986, Endocrinology.

[156]  W. Bennett,et al.  Modification of experimental gentamicin nephrotoxicity by selective parathyroidectomy. , 1985, The American journal of physiology.

[157]  P. Cadnapaphornchai,et al.  Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. , 1985, The American journal of medicine.

[158]  R. Cronin,et al.  Protective effect of thyroxine but not parathyroidectomy on gentamicin nephrotoxicity. , 1985, The American journal of physiology.

[159]  H. Harter,et al.  Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. , 1984, The Journal of clinical investigation.

[160]  J. Brière,et al.  Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemias , 1984 .

[161]  M. G. Kane,et al.  Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. , 1983, The American journal of medicine.

[162]  K. Hansen,et al.  Changes in 25-hydroxyvitamin D3 alpha- and 24-hydroxylase activities of kidney cells isolated from rats with either unilateral kidney damage or acute renal insufficiency. , 1983, Endocrinology.

[163]  T. R. Abbott.  Changes in serum calcium fractions and citrate concentrations during massive blood transfusions and cardiopulmonary bypass. , 1983, British journal of anaesthesia.

[164]  M. Levi,et al.  Control of renal hemodynamics and glomerular filtration rate in chronic hypercalcemia. Role of prostaglandins, renin-angiotensin system, and calcium. , 1983, The Journal of clinical investigation.

[165]  F. Lang,et al.  The effect of respiratory and metabolic acid‐base changes on ionized calcium concentration: in vivo and in vitro experiments in man and rat , 1982, European journal of clinical investigation.

[166]  R. Kremer,et al.  PARATHYROID HORMONE STIMULATES MAMMALIAN RENAL 25-HYDROXYVITAMIN D3-1α-HYDROXYLASE IN VITRO , 1982 .

[167]  S. Madsen,et al.  Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure. , 1981, The Journal of clinical endocrinology and metabolism.

[168]  M. Haussler,et al.  The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. , 1981, The New England journal of medicine.

[169]  H. Kawashima,et al.  Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[170]  L. Drop,et al.  Role of the systemic vasculature in the hemodynamic response to changes in plasma ionized calcium. , 1980, Archives of surgery.

[171]  G. Richet,et al.  Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma. , 1979, British medical journal.

[172]  J. McDonald,et al.  Relationship of free and total calcium in hypercalcemic conditions. , 1979, The Journal of clinical endocrinology and metabolism.

[173]  M Kaye,et al.  Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites. , 1978, Kidney international.

[174]  F. Kokot,et al.  Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure. , 1978, Kidney international.

[175]  H. Jüppner,et al.  Endocrinological aspects of PTH metabolism in the kidney. , 1978, Contributions to nephrology.

[176]  J. Bethune,et al.  Hyperphosphatemia in lactic acidosis. , 1977, The New England journal of medicine.

[177]  J. Haddad,et al.  Acute administration of 25-hydroxycholecalciferol in man. , 1976, The Journal of clinical endocrinology and metabolism.

[178]  A. Szent-Györgyi.  Calcium regulation of muscle contraction. , 1975, Biophysical journal.

[179]  A. Arieff,et al.  Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. , 1974, Kidney international.

[180]  D. Fraser,et al.  Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. , 1973, Nature: New biology.

[181]  D. Orrell.  Albumin as an aid to the interpretation of serum calcium. , 1971, Clinica chimica acta; international journal of clinical chemistry.